Target intelligence / Profile preview

LAP3 antisense RNA 1 (LAP3-AS1)

Target
LAP3-AS1
Molecular classification
Long non-coding RNA
01

Overview

LAP3 antisense RNA 1 (LAP3-AS1), also known as MED28 divergent transcript (MED28-DT), is a long non-coding RNA (lncRNA) located antisense to the LAP3 gene and divergent from the MED28 gene. It is also known in genome annotation as AC006160.1. LAP3-AS1 is not currently recognized as a receptor, enzyme, transporter, or other classical drug target in therapeutic literature. LncRNAs like LAP3-AS1 are generally involved in regulation of gene expression, often through chromatin remodeling, regulation of transcription, or other epigenetic processes. However, detailed functions for LAP3-AS1 or MED28-DT have not been validated in the peer-reviewed literature. Its description, nomenclature, and function remain limited to genomic annotation, with no established role in disease, drug targeting, or biomarker use. The alias “MED28-DT” is considered non-standard, with “LAP3 antisense RNA 1 (LAP3-AS1)” being the best-characterized and accepted name.

Other names
LAP3-AS1AC006160.1LAP3 antisense RNA 1MED28-DT
02

Biological functions

Other (possible regulation of nearby gene transcription)
03

Disease associations

Other (potential disease association data unavailable)

Beyond the preview

Go deeper on LAP3 antisense RNA 1 (LAP3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAP3 antisense RNA 1 (LAP3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call